Market Access

---

Market Access brings together many interdependent areas and is an important aspect of the launch of Advanced Therapy Medicinal Products (ATMPs), helping to make the approval process successful. Here are some possible tasks to improve market access for ATMPs according to G-BA (Federal Joint Committee):

 

1. Market analysis
   A thorough market analysis can help to understand the potential of the ATMP in terms of acceptance by target groups, the competitive landscape and willingness to pay.
    
2. Benefit assessment
   A benefit assessment can show the added value of the ATMP compared to other treatments and demonstrate the cost-effectiveness of the product. The benefit assessment can help communicate the added value of the ATMP and can feed into the authorisation process.
    
3. Reimbursement
   Reimbursement is an important factor for market access of ATMPs. It is important to understand the reimbursement criteria of the different health insurance funds and the regulations of the G-BA to ensure that the ATMP is accessible to patients.
    
4. Collaboration with stakeholders
   Collaboration with stakeholders such as physicians, patient organisations and health insurance companies can help to increase the acceptance and use of the ATMP. Close collaboration with these stakeholders can also help address and resolve concerns and issues in the approval process.
    
5. Communication
   Clear and convincing communication about the benefits of the ATMP and its use can help increase uptake. Targeted communication to stakeholders can also help address and resolve concerns and issues.